ID   LIF_RAT                 Reviewed;         202 AA.
AC   P17777;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   24-JUL-2024, entry version 126.
DE   RecName: Full=Leukemia inhibitory factor;
DE            Short=LIF;
DE   AltName: Full=Cholinergic neuronal differentiation factor;
DE   Flags: Precursor;
GN   Name=Lif;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=2512641; DOI=10.1126/science.2512641;
RA   Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M.-J.,
RA   Patterson P.H.;
RT   "The cholinergic neuronal differentiation factor from heart cells is
RT   identical to leukemia inhibitory factor.";
RL   Science 246:1412-1416(1989).
CC   -!- FUNCTION: LIF has the capacity to induce terminal differentiation in
CC       leukemic cells. Its activities include the induction of hematopoietic
CC       differentiation in normal and myeloid leukemia cells, the induction of
CC       neuronal cell differentiation, and the stimulation of acute-phase
CC       protein synthesis in hepatocytes.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the LIF/OSM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32748; AAA41530.1; -; mRNA.
DR   PIR; A40078; A40078.
DR   AlphaFoldDB; P17777; -.
DR   SMR; P17777; -.
DR   STRING; 10116.ENSRNOP00000009313; -.
DR   GlyCosmos; P17777; 7 sites, No reported glycans.
DR   GlyGen; P17777; 7 sites.
DR   PaxDb; 10116-ENSRNOP00000009313; -.
DR   UCSC; RGD:620865; rat.
DR   AGR; RGD:620865; -.
DR   RGD; 620865; Lif.
DR   eggNOG; ENOG502S3JD; Eukaryota.
DR   InParanoid; P17777; -.
DR   PhylomeDB; P17777; -.
DR   Reactome; R-RNO-6788467; IL-6-type cytokine receptor ligand interactions.
DR   PRO; PR:P17777; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005125; F:cytokine activity; ISO:RGD.
DR   GO; GO:0008083; F:growth factor activity; ISO:RGD.
DR   GO; GO:0005146; F:leukemia inhibitory factor receptor binding; IMP:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IMP:RGD.
DR   GO; GO:0048708; P:astrocyte differentiation; IMP:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0097696; P:cell surface receptor signaling pathway via STAT; ISO:RGD.
DR   GO; GO:0046697; P:decidualization; ISO:RGD.
DR   GO; GO:0007566; P:embryo implantation; ISO:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0048861; P:leukemia inhibitory factor signaling pathway; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0060463; P:lung lobe morphogenesis; ISO:RGD.
DR   GO; GO:0060426; P:lung vasculature development; ISO:RGD.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; ISO:RGD.
DR   GO; GO:0140013; P:meiotic nuclear division; ISO:RGD.
DR   GO; GO:0048644; P:muscle organ morphogenesis; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; ISO:RGD.
DR   GO; GO:0045835; P:negative regulation of meiotic nuclear division; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; ISO:RGD.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; ISO:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0051461; P:positive regulation of corticotropin secretion; IDA:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0072108; P:positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0045595; P:regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IDA:RGD.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:RGD.
DR   GO; GO:0060708; P:spongiotrophoblast differentiation; ISO:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; ISO:RGD.
DR   GO; GO:0060290; P:transdifferentiation; IMP:RGD.
DR   GO; GO:0060707; P:trophoblast giant cell differentiation; ISO:RGD.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR003624; Leukemia_IF.
DR   InterPro; IPR001581; Leukemia_IF/oncostatin.
DR   InterPro; IPR019827; Leukemia_IF/oncostatin_CS.
DR   PANTHER; PTHR10633; LEUKEMIA INHIBITORY FACTOR; 1.
DR   PANTHER; PTHR10633:SF0; LEUKEMIA INHIBITORY FACTOR; 1.
DR   Pfam; PF01291; LIF_OSM; 1.
DR   PRINTS; PR01883; LEUKAEMIAIF.
DR   SMART; SM00080; LIF_OSM; 1.
DR   SUPFAM; SSF47266; 4-helical cytokines; 1.
DR   PROSITE; PS00590; LIF_OSM; 1.
PE   2: Evidence at transcript level;
KW   Cytokine; Disulfide bond; Glycoprotein; Growth factor; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..22
FT   CHAIN           23..202
FT                   /note="Leukemia inhibitory factor"
FT                   /id="PRO_0000017718"
FT   CARBOHYD        31
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        85
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        118
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        34..156
FT                   /evidence="ECO:0000250"
FT   DISULFID        40..153
FT                   /evidence="ECO:0000250"
FT   DISULFID        82..185
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   202 AA;  22113 MW;  022373582D296164 CRC64;
     MKVLAAGIVP LLLILHWKHG AGSPLPITPV NATCAIRHPC HGNLMNQIKS QLAQLNGSAN
     ALFISYYTAQ GEPFPNNVDK LCAPNMTDFP PFHANGTEKT KLVELYRMVT YLGASLTNIT
     WDQKNLNPTA VSLQIKLNAT TDVMRGLLSS VLCRLCNKYH VGHVDVPCVP DNSSKEAFQR
     KKLGCQLLGT YKQVISVLAQ AF
//
